Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
about
Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.Cisplatin ototoxicity and protection: clinical and experimental studiesGene therapy for the inner earInner ear symptoms and disease: pathophysiological understanding and therapeutic optionsPermeation, regulation and control of expression of TRP channels by trace metal ionsAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityHCN1 and HCN2 proteins are expressed in cochlear hair cells: HCN1 can form a ternary complex with protocadherin 15 CD3 and F-actin-binding filamin A or can interact with HCN2siRNA-mediated knock-down of NOX3: therapy for hearing loss?Cisplatin-Associated Ototoxicity: A Review for the Health ProfessionalProtective Effect of Tempol against Cisplatin-Induced Ototoxicity.Inner ear supporting cells protect hair cells by secreting HSP70.Mechanism of alpha-lipoic acid in attenuating kanamycin-induced ototoxicity.Regeneration of mammalian cochlear and vestibular hair cells through Hes1/Hes5 modulation with siRNACisplatin ototoxicity blocks sensory regeneration in the avian inner earTRPV1: A Potential Drug Target for Treating Various Diseases.Attenuation of noise-induced hearing loss using methylene blue.Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea.Ototoxicity in dogs and cats.The design and screening of drugs to prevent acquired sensorineural hearing lossGentamicin rapidly inhibits mitochondrial metabolism in high-frequency cochlear outer hair cells.NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing lossShort interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammationDrug delivery for treatment of inner ear disease: current state of knowledgeEarly investigational drugs for hearing loss.Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.Nox proteins in signal transductionReactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models.Mechanisms of cisplatin ototoxicity: theoretical review.Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists.Crosstalk between calcium and reactive oxygen species signaling in cancer.Calpain mediated cisplatin-induced ototoxicity in mice.Effect of capsaicin on potassium conductance and electromotility of the guinea pig outer hair cell.Short interfering RNA against Bax attenuates TNFα-induced ototoxicity in rat organ of Corti explants.Drofenine: A 2-APB Analogue with Greater Selectivity for Human TRPV3.Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.Synergic prooxidant, apoptotic and TRPV1 channel activator effects of alpha-lipoic acid and cisplatin in MCF-7 breast cancer cells.CRISPR/Cas9-mediated knockout of Lim-domain only four retards organ of Corti cell growth.
P2860
Q24615296-89B49362-C351-47D8-A536-DE8FEE358EFBQ24628775-E7486F36-4CA3-40E0-9606-C80F2D08AA19Q26851920-55D2CBC5-0246-4149-BEBD-76BE3C760F7EQ26997318-1CC2E3B1-AE85-480F-9629-029DA60E36BBQ26999694-AF85C4EA-54DD-4171-A9E2-669BF939F0EFQ28080615-6DAA1F26-35D0-4A00-8438-3E53C3CF3552Q28584355-84892C4E-4006-4349-9DEE-052345915FE9Q30355898-A3F6A79A-341E-463F-8C44-CBB80E390A2EQ30365226-F7346685-335F-4BB1-BC09-341994294924Q30368102-26731CE0-55BD-4234-AD2E-3741707700BAQ30413856-CA99CCF6-DD28-41F6-B476-4220C99AF5E2Q30428558-2D449A65-9BAB-4D8D-BE8D-1E3053FF6E48Q30429653-A8F34DBA-4C05-4F1C-9A4E-67D38B42C331Q30434857-953DDA5B-720C-4A17-8F54-C0993423033AQ30434994-CCFBFE6B-6F1E-4938-8654-C3FF96AD4EDAQ30439567-75390B57-5940-482E-8691-EA1CBB1DD881Q30443547-5CFE6C2A-A6DB-4AA9-A45C-9E09075DBB9BQ30447867-B7D9BFAC-915C-4BFD-98EA-CCD0FB7146E2Q30465748-B583114A-1DC0-4D09-B8A2-D8E9D127E101Q30466528-D3C13D5A-16C9-48EC-A4F6-71399B7DDD32Q30469563-1DCF9D19-3286-4855-BB1E-388A4E573553Q30473608-BB794103-F46E-44E6-8816-AEBC5BAD2DD3Q30476020-9F87D868-FD8B-4E93-83AF-C518844D8ED9Q33847686-33CBC6D9-BFBF-4B42-BF55-A57775682764Q34110153-549E84C6-77E5-4286-BB5F-2250248BA2C6Q36057728-00BBA21D-70E9-4E6E-8FD6-C8044484CC5EQ36768399-FE380BF3-B122-4B0A-9779-69AB0D3E9598Q37392163-A08372FE-AF10-4DE8-84F4-37610AEC53D9Q38010040-6F2B7E5B-E479-4CB0-A948-4D710C56B1ADQ38104833-CFE6AB0C-1515-464C-B8DC-D931BF431126Q38637751-23143F73-E5AB-475C-B5D3-5A39E7E300B7Q39038882-61EF0618-F76F-42E6-A928-C9D8E08FA20AQ39112253-4AC41575-7DF0-4C91-8D9D-EE0BB29D69CBQ41828656-90791F01-E64A-4614-BA24-1911727B40BCQ41996963-BDAA474F-60BE-49CE-B9CC-8C563D521BD8Q42520601-C53693E0-E6F4-4348-885C-F4C07F04990AQ42756787-5D224DBB-661B-48E8-9A49-97D6790A32B5Q46256727-1F257A34-B17E-4A59-BD18-4BB222B2119EQ46315097-C321CF53-786A-42EB-9F0D-6205A8AD0649Q47396835-3373399F-8EDD-46E0-96E5-3A133A7D99FA
P2860
Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Short interfering RNA against ...... duced hearing loss in the rat.
@ast
Short interfering RNA against ...... duced hearing loss in the rat.
@en
type
label
Short interfering RNA against ...... duced hearing loss in the rat.
@ast
Short interfering RNA against ...... duced hearing loss in the rat.
@en
prefLabel
Short interfering RNA against ...... duced hearing loss in the rat.
@ast
Short interfering RNA against ...... duced hearing loss in the rat.
@en
P2093
P2860
P1476
Short interfering RNA against ...... duced hearing loss in the rat.
@en
P2093
Craig Whitworth
Debashree Mukherjea
Jennifer R Bunch
Jeremy G Turner
Leonard P Rybak
Sarvesh Jajoo
Vickram Ramkumar
P2860
P304
13056-13065
P356
10.1523/JNEUROSCI.1307-08.2008
P407
P577
2008-12-01T00:00:00Z